clonidine has been researched along with berotek in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Korkhov, VV; Mats, MN; Sulukhiia, RV | 1 |
Hu, CY; Mersmann, HJ; Novakofski, J | 1 |
Bielefeld, FW; Schümann, HJ | 1 |
Caicedo, M; Cepelík, J; Dedina, M; Hynie, S | 1 |
9 other study(ies) available for clonidine and berotek
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[The combined and separate use of prostaglandin and adrenergic agents for the purpose of the experimental correction of uterine contractile activity].
Topics: Animals; Clonidine; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Female; Fenoterol; Membrane Potentials; Oxytocin; Pregnancy; Rats; Sympathomimetics; Uterine Contraction | 1989 |
Hormonal control of porcine adipose tissue fatty acid release and cyclic AMP concentration.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Animals; Clonidine; Cyclic AMP; Dobutamine; Epinephrine; Fatty Acids, Nonesterified; Female; Fenoterol; Isoproterenol; Lipolysis; Phentolamine; Swine; Theophylline | 1987 |
The effect of urapidil on cardiac alpha- and beta-adrenoceptors.
Topics: Animals; Clonidine; Drug Interactions; Female; Fenoterol; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Norepinephrine; Phenylephrine; Piperazines; Rabbits; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1986 |
Effects of drugs acting on adrenergic and adenosine receptors on the intraocular pressure and the activity of adenylyl cyclase in ciliary processes and their sensitivity to pertussis toxin.
Topics: Adenosine; Adenylate Cyclase Toxin; Adenylyl Cyclases; Adrenergic Agonists; Adrenergic alpha-Antagonists; Animals; Ciliary Body; Clonidine; Epinephrine; Fenoterol; Intraocular Pressure; Pertussis Toxin; Purinergic P1 Receptor Agonists; Rabbits; Receptors, Adrenergic; Receptors, Purinergic P1; Virulence Factors, Bordetella; Yohimbine | 1997 |